TMVR: Continuing the Paradigm Shift in Valvular Heart Disease Therapy

[...]the MV is significantly more complex, both anatomically and physiologically, than the aortic valve. [...]we must remember that this report is truly of a short-term follow-up and that we have much to learn regarding the safety of this approach in terms of the durability of the bioprosthesis, the alignment and continued security of the device, the potential for erosion, the possibility of outflow tract obstruction, and the need for anticoagulation over the long term (9).